E. Lindner et al. / Journal of Organometallic Chemistry 665 (2003) 176ꢀ
/
185
183
C34H36Cl2N2P2Ru: C, 57.73; H, 4.68; Cl, 9.87; N,
3.89%.
7.10ꢀ
(ppm) 42.88. 13C{1H}-NMR (CDCl3): d (ppm) 19.54 (s,
CH2), 24.79 (s, CH3), 26.48 (m [26]a, Nꢃ32.02 Hz,
PCH2), 34.45 (s, C(CH3)2), 49.97 (s, NCH2), 128.13 (m
[26]b, Nꢃ8.08 Hz, m-C6H5), 129.24 (s, p-C6H5), 133.61
(br, o-C6H5), 136.24 (m, i-C6H5). FABMS; (m/z): 681.1
[Mꢁ]. Anal. Found: C, 55.98; H, 5.87; Cl, 10.33; N,
4.08. Calc. for C32H40Cl2N2P2Ru: C, 55.98; H, 5.48; Cl,
9.35; N, 3.64%.
/
7.50 (m, 20H, C6H5). 31P{1H}-NMR (CDCl3): d
/
4.2.7. 3L7
Complex 2 (500 mg, 0.50 mmol) was treated with L7
(0.116 g, 0.55 mmol) to give 3L7. Yield 374 mg (96%) of a
yellow powder, m.p. 318 8C (dec.). 1H-NMR (CDCl3): d
(ppm) 1.87 (m, 2H, CH2), 2.76 (br, 4H, PCH2), 3.00 (d,
/
3JHH
3JHH
C6H3). 31P{1H}-NMR (CDCl3):
13C{1H}-NMR (CDCl3): d (ppm) 21.40 (s, CH2),
28.20 (m [26]a, Nꢃ35.02 Hz, PCH2), 65.69 (s, HCN),
ꢃ
/
8.80 Hz, 2H, NH), 3.50 (m, 2H, CHN) 4.24 (d,
8.8 Hz, 2H, NH), 6.64ꢀ7.73 (m, 23H, C6H5,
(ppm) 41.53.
ꢃ
/
/
d
4.2.11. 3L11
Complex 2 (500 mg, 0.5 mmol) was treated with L11
(0.066 ml, 0.55 mmol) to give 3L11. Yield 291 mg (84%)
/
125.84, 128.24, 130.54, 131.23, 131.36, 131.95, 139.34,
148.62 (C6H5). FABMS; (m/z): 796.2 [Mꢁ]. Anal.
Found: C, 61.81; H, 5.31; Cl, 8.90; N, 3.52. Calc. for
C41H42Cl2N2P2Ru: C, 61.66; H, 5.17; Cl, 8.80; N, 3.21%.
of a yellow powder, m.p. 280 8C (dec.). 1H-NMR
3
(CDCl3): d (ppm) 0.35 (t, 3H, JHH
ꢃ7.5 Hz, CH3),
/
1.07 (m, 1H, NCH), 1.27 (m, 2H, CH2CH3), 1.48 (m,
2H, PCH2CH2), 1.54 (m, 2H, CHCH2), 2.58 (s, 4H,
NH2), 2.95 (m, 6H, PCH2, NCH2), 7.10ꢀ
C6H5). 31P{1H}-NMR (CDCl3): d (ppm) 42.24, 42.53
(AB pattern, 2JPP 52.20 Hz). 13C{1H}-NMR (CDCl3):
d (ppm) 9.70 (s, CH3), 19.49 (s, PCH2CH2), 26.46 (2m,
PCH2), 33.15 (s, CH2CH3), 34.85 (s, CHCH2CH2),
40.50 (s, NCH2), 52.35 (s, NCH), 127.83, 128.32,
/
7.50 (m, 20H,
4.2.8. 3L8
Complex 2 (500 mg, 0.5 mmol) was treated with L8
(0.116 g, 0.55 mmol) to give 3L8. Yield 367 mg (94%) of
a yellow powder, m.p. 318 8C (dec.). 1H-NMR (CDCl3):
d (ppm) 1.87 (m, 2H, CH2), 2.75 (br, 4H, PCH2), 3.05
ꢃ
/
(d, 3JHH
3JHH
8.8 Hz, 2H, NH), 6.5ꢀ
C6H3). 31P{1H}-NMR (CDCl3):
13C{1H}-NMR (CDCl3): d (ppm) 19.98 (s, CH2),
26.57 (m [26]a, Nꢃ35.02 Hz, PCH2), 64.03 (s, HCN),
ꢃ
/
8.8 Hz, 2H, NH), 3.55 (m, 2H, CHN) 4.22 (d,
7.8 (m, 23H, C6H5,
(ppm) 41.54.
129.37, 133.06, 134.04 (C6H5). FABꢀMS; (m/z): 686.1
/
ꢃ
/
/
[Mꢁ]. Anal. Found: C, 55.98; H, 5.87; Cl, 10.33; N,
4.08. Calc. for C32H40Cl2N2P2Ru: C, 55.78; H, 5.76; Cl,
10.45; N, 4.07%.
d
/
129.5, 130.2, 130.5, 131.0, 131.1, 131.5, 135.3, 142.7
(C6H5). FABMS; (m/z): 796.1 [Mꢁ]. Anal. Found: C,
61.81; H, 5.31; Cl, 8.90; N, 3.52. Calc. for
C41H42Cl2N2P2Ru: C, 61.69; H, 5.10; Cl, 8.74; N,
3.76%.
4.2.12. 3L12
Complex 2 (500 mg, 0.5 mmol) was treated with L12
(0.057 ml, 0.55 mmol) to give 3L12. Yield 219 mg (65%)
of a yellow powder, m.p. 180 8C (dec.). 1H-NMR
(CDCl3): d (ppm) 0.78 (m, 4H, CH2CH2N), 1.18 (m,
4H, CH2N), 1.59 (m, 4H, CH2), 2.63, 2.74 (m, 8H,
PCH2, NH2), 7.12ꢀ
(CDCl3): d (ppm) 41.71. 13C{1H}-NMR (CDCl3): d
(ppm) 19.57 (s, CH2), 26.87 (m [26]a, Nꢃ34.02 Hz,
PCH2), 28.91 (s, CH2CH2N), 41.91 (s, NCH2), 128.24,
129.43, 132.52, 133.93 (C6H5). FABMS; (m/z): 672.1
[Mꢁ]. Anal. Found: C, 55.36; H, 5.69; Cl, 10.54; N,
4.17. Calc. for C31H38Cl2N2P2Ru: C, 55.38; H, 5.47; Cl,
10.35; N, 3.84%.
4.2.9. 3L9
/
7.68 (m, 20H, C6H5). 31P{1H}-NMR
Complex 2 (500 mg, 0.50 mmol) was treated with L9
(0.046 ml, 0.55 mmol) to give 3L9. Yield 317 mg (96%)
of a yellow powder, m.p. 288 8C (dec.). 1H-NMR
(CDCl3): d (ppm) 1.52 (br, 6H, N(CH2)3, 1.84 (m, 2H,
/
CH2), 2.74, 2.81 (br, 8H, NH2, PCH2), 7.10ꢀ7.60 (m,
/
20H, C6H5). 31P{1H}-NMR (CDCl3): d (ppm) 42.53.
13C{1H}-NMR (CDCl3): d (ppm) 19.52 (s, PCH2CH2),
26.56 (m [26]a, Nꢃ/35.02 Hz, PCH2), 29.47 (s,
NCH2CH2), 40.29 (s, NCH2), 128.06 (m [26]b, Nꢃ
/
4.3. General procedure for the catalytic studies
8.08 Hz, m-C6H5), 129.4 (s, p-C6H5), 133.6 (br, o-
C6H5), 136.4 (m, i-C6H5). FABMS; (m/z): 685.1 [Mꢁ].
Anal. Found: C, 54.71; H, 5.51; Cl, 10.77; N, 4.25. Calc.
for C30H36Cl2N2P2Ru: C, 54.78; H, 5.17; Cl, 10.51; N,
3.99%.
The respective diamine[bis(diphenylphosphino)propa-
ne]ruthenium(II) complexes 3L1ꢀ3L12, (0.012 mmol)
/
was placed in a 200 ml Schlenk tube and solid KOH
(0.12 mmol) was added as a cocatalyst. The solid
mixture was stirred and warmed during the evacuation
process to remove oxygen and water. Subsequently the
Schlenk tube was filled with argon and 20 ml of 2-
propanol. The mixture was vigorously stirred, degassed
4.2.10. 3L10
Complex 2 (500 mg, 0.5 mmol) was treated with L10
(0.065 ml, 0.55 mmol) to give 3L10. Yield 291 mg (90%)
of a yellow powder, m.p. 270 8C (dec.). 1H-NMR
(CDCl3): d (ppm) 0.75 (s, 6H, CH3), 1.79 (m, 2H,
CH2), 2.50 (br, 4H, NCH2), 2.73 (br, 8H, NH2, PCH2),
by two freezeꢀ
/
thaw cycles, and then sonicated for 20ꢀ40
/
min (this is important to complete the dissolving of the
catalyst and cocatalyst). A solution of trans-4-phenyl-3-